Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Antimicrobial Resistance of Clinically Important Bacteria Isolated from Burn Wound Infections in Children

화상감염 소아환자에서 분리된 주요 균종에 대한 항생제의 내성률

  • 강주연 (덕성여자대학교 약학대학) ;
  • 신혜순 (덕성여자대학교 약학대학)
  • Received : 2012.12.28
  • Accepted : 2013.03.04
  • Published : 2013.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background & Objectives: Burn injury mortality and septic complication are frequent and well-known in burned pediatric patients. The overuse of antibiotics is the base for development of wound infection by resistant microorganisms as well as opportunist agents. Methods: We have carried out a study of the bacterial profile and antimicrobial resistance clinically important bacteria isolated from burn wound infections in children patients. The most common isolate from burn wound cultures was Pseudomonas aeruginosa (26.8%), followed by Staphylococcus aureus (25.4%), Acinetobacter baumannii (12.7%), coagulase negative staphylococcus (12.0%), Enterococcus faecium (7.7%), Escherichia coli (4.9%), Enterococcus faecalis (3.7%), Burkholderia cepacia (3.0%), Enterobacter cloacae (2.3%) and Klebsiella pneumonia (2.3%). Colistin was very significantly effective drug in gram negative organism, such as Pseudomonas aeruginosa and Acinetobacter baumannii. Results & Conclusion: The resistance rates were 65% and 98% to piperacillin, 63% and 97% to ceftazidime, 28% and 50% to levofloxacin. The most effective antibiotic in gram positive organism, such as Staphylococcus aureus, coagulase negative staphylococcus were moxifloxacin. The resistance rates were 83% and 64% to ciprofloxacin, 80% and 17% to clindamycin.

Keywords

References

  1. Mayhall CG. The Epidemiology of Burn Wound Infections: Then and Now. Clinil Infect Dis 2003; 37: 543-50. https://doi.org/10.1086/376993
  2. Revathi G, Puri J, Jain BK. Bacteriology of burn. Burn 1998; 24: 347-9. https://doi.org/10.1016/S0305-4179(98)00009-6
  3. Ozumba UC, Jiburum BC. Bacteriology of burn wounds in Enugu, Nigeria. Burn 2000; 26: 178-80. https://doi.org/10.1016/S0305-4179(99)00075-3
  4. Mousa HAL. Aerobic, anaerobic and fungal burn wound infections. J hosp infect 1997; 37(4): 317-23. https://doi.org/10.1016/S0195-6701(97)90148-1
  5. Song WK, Lee KM, Shin DH, et al., Antimicrobial susceptibility patterns of predominant bacteria isolated from the burn patients. J Korean Soc Chemother 1999; 17(1): 47-52.
  6. Lawrence JC. Burn bacteriology during the last 50 years. Burn 1992; 18(2): S23-S29. https://doi.org/10.1016/0305-4179(92)90066-4
  7. Boucher HW, Talbot GH, Bradley JS, et al., Bad bugs, no drugs: no escape! an update from the infectious diseases society of America. Clin Infect Dis 2009; 48: 1-12. https://doi.org/10.1086/595011
  8. Williams FN, Herndon DN, Hawkins HK, et al., The leading causes of death after burn injury in a single pediatric burn center. Crit Care 2009; 13(6): R183. https://doi.org/10.1186/cc8170
  9. Rosanova M, Epelbaum C, Noman A, et al., The of colistin in a pediatric burn unit in Argentina. J Buren Care Res 2009; 30(4): 612-15. https://doi.org/10.1097/BCR.0b013e3181abffb6
  10. Rodgers GL, Mortensen J, Fisher MC, et al., Predictors of infectious complications after burn injuries in children. Pediatr Infect Dis J 2000; 19(10): 990-5. https://doi.org/10.1097/00006454-200010000-00010
  11. Neu HC. The crisis in antibiotic resistance. Science 1992;257: 1064-73. https://doi.org/10.1126/science.257.5073.1064
  12. Morris AK, Masterton RC. Antibiotic resistance surveillance: action for international studies. J of Antimicrob Chemother 2002; 49: 7-10.
  13. Lee KW, Kim MY, Kang SH, et al., Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and espanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli. Yonsei Medical Journal 2003; 454(4): 571-8.
  14. Jeon JG, Min HK, Kim JM, et al., Study of results of bacterial culture and antibiotic sensitivity in burn patients. Koran J Dermatol 2001; 39(12): 1391-6.
  15. Byun HW, Kin CG, Kin JK, et al., Clinical characteristics and risk factors of mortality among severe burn patients with isolation of vancomycin-resistant enterococci. Infection and Chemotherapy 2005; 37(5): 265-70.
  16. Yoon YK, Kim MJ, Sohn JW, et al., Surveillance of antimicrobial use and antimicrobial resistance. Infection and Chemotherapy 2008; 40(2): 93-101. https://doi.org/10.3947/ic.2008.40.2.93
  17. Kim TH, Lee, YS, Lee MK, et al., Species distribution and susceptibilities to azoles of candida species including C. tropicalis in a Tertiary Burn Center. Korean J Clin Microbiol 2010; 13(2): 79-84. https://doi.org/10.5145/KJCM.2010.13.2.79
  18. Lee HK, Kim CK, Lee JW, et al., Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2005 and 2006. Korean J Clin Microbiol 2007; 10(1): 59-69.
  19. Hong SG, Yong DE, Lee KW, et al., Antimicrobial resistance of clinically important bacteria isolated from hospitals located in representative provinces of Korea. Korean J Clin Microbiol 2003; 6(1): 29-36.
  20. Lee KW, Chang CL, Lee NY, et al., Korean nationwide surveillance of antimicrobial resistance of bacteria in 1998. Yonsei Medical Journal 2000; 41(4): 497-506.
  21. Chong YS, Lee KW, Park YJ, et al., Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997. Yonsei Medical Journal 1998; 39(6): 569-77.
  22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: tenth informational supplement, Wayne, PA, NCCLS, 2000.
  23. Bernal FJG, Torrero V, Regalado J, et al., Bacteriology in burn patients undergoing mechanical ventilation. Burn 2006; 26: 731-6.
  24. Kang SO, Lee HJ, Lee SH. An evaluation of antibiotic use in the hospitalized burn patients. Kor J Clin Pharm 2002; 12(2): 55-64.
  25. Obritsch MD, Fish DN, MacLaren R, et al., National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004; 48: 4606-10. https://doi.org/10.1128/AAC.48.12.4606-4610.2004
  26. Raja NS, Singh NN, Antimicrobial susceptibility pattern of antimicrobial resistance in Pseudomonas aeruginosa in a tertiary care hospital J Microbial Immunol infect 2007; 40(1): 45-9.
  27. Lee KW, Kim MN, Kim JS, et al., Further increase in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. And P. aeruginosa in Korea: KONSAR study 2009. Yonsei Medical Journal 2011; 52(5): 793-802. https://doi.org/10.3349/ymj.2011.52.5.793